Application of pharmacogenetics to psychotic disorders: The first consensus conference. Date and Place of Meeting: 12 July 1998, Marriott Hotel, 500 Argyle Street, Glasgow

Schizophrenia Research

Volumn 37, Issue 2, 1999, Pages 191-196

  Rietschel, Marcella ^a,e   Kennedy, J L ^e   Macciardi, F ^e   Meltzer, H Y ^e   Breier, A ^e   DeLisi, L E ^e   Henn, F ^e   Kalow, W ^e   Kerwin, R ^e   Kurth, J ^e   Lerer, B ^e   Malhotra, A ^e   Masellis, M ^e   Moller H J ^e   Ozdemir, V ^e   Peusken, J ^e   Schooler, N R ^e   Steen, V M ^e   Kane, J M ^e   Marder, S ^e   No M M ^e   Awad, A G ^e   more..

^a UNIVERSITY OF BONN   (Germany)

^b CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

^c UNIVERSITY OF MILAN   (Italy)

^d Psychiatric Hospital at Vanderbilt   (United States)

^e NONE

Author keywords

[No Author keywords available]

Indexed keywords

CONFERENCE PAPER; DEMOGRAPHY; DIAGNOSTIC PROCEDURE; DISEASE DURATION; DRUG BLOOD LEVEL; GENETIC LINKAGE; NEUROPSYCHOLOGICAL TEST; PATIENT SELECTION; PHARMACOGENETICS; PRIORITY JOURNAL; PSYCHOSIS; SYMPTOMATOLOGY;

EID: 0033602828     PISSN: 09209964     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0920-9964(98)00153-4     Document Type: Article

References (33)

1. American Psychiatric Association (APA), 1994. Diagnostic and Statistical Manual of Mental Disorders, 4th ed. American Pychiatric Association, Washington D.C.
2. Andreasen, N.C., 1984a. Scale for the Assessment of Negative Symptoms (SANS). University of Iowa College of Medicine, Department of Psychiatry, Iowa City.
3. Andreasen, N.C., 1984b. Scale for the Assessment of Positive Symptoms (SAPS). University of Iowa College of Medicine, Department of Psychiatry, Iowa City.
4. Arranz M., Collier D., Sodhi M., Ball D., Roberts G., Price J., Sham P., Kerwin R. Association between clozapine response and allelic variation in 5-HT2A receptor gene. Lancet. 346:1995;281-282.
5. Arranz M.J., Collier D.A., Munro J., Sham P., Kirov G., Sodhi M., Roberts G., Price J., Kerwin R.W. Analysis of a structural polymorphism in the 5-HT2A receptor and clinical response to clozapine. Neurosci. Lett. 217:1996;177-178.
6. 2A receptor gene and response to clozapine. Molecular Psychiatry. 3:1998;61-66.
7. Arranz M.J., Munro P., Kirov G., Murray R.M., Collier D.A., Kerwin R.W. Meta-analysis of studies on genetic variation in 5-HT42A receptors and clozapine response. Schizophr. Res. 32:1998;93-99.
8. Endicott J., Spitzer R.L. A diagnostic interview: The schedule for affective disorders and schizophrenia. Arch. Gen. Psychiatry. 35:1978;837-844.
9. Kay S.R., Opler L.A., Lindenmaier J.P. the Positive and Negative Syndrome Scale (PANSS) for Schizophrenia. Schizophr. Bull. 13:1987;261-276.
10. Kay S.R., Opler L.A., Lindenmaier J.P. the Positive and Negative Syndrome Scale (PANSS): Rationale and standardisation. Br. J. Psychiatry. 155(Suppl.7):1989;59-65.
11. Lander E., Kruglyak L. Genetic dissection of complex traits:guidelines for interpreting and reporting linkage results. Nat. Genet. 11:1995;241-247.
12. McGuffin P., Farmer A.E. A polydiagnostic application of the operational criteria in studies of psychotic illness. Arch. Gen. Psychiatry. 48:1991;764-770.
13. Kohn Y., Ebstein R.P., Heresco-Levy U., Shapira B., Nemanov L., Gritsenko I., Avnon M., Lerer B. Dopamine D4 receptor gene polymorphisms: relation to ethnicity, no association with schizophrenia and response to clozapine in Israeli subjects. Eur. Neuropsychopharmacology. 7:1997;39-43.
14. 2A receptor gene and the antipsychotic response to clozapine. Am. J. Psychiatry. 153:1996;1092-1094.
15. 23Ser polymorphism. Neuroreport. 7:1996;2100-2102.
16. Masellis M., Paterson A.D., Badri F., Lieberman J.A., Meltzer H.Y., Cavazzoni P., Kennedy J.L. Genetic variation of 5-HT2A receptor and response to clozapine. Lancet. 346:1995;1108.
17. Masellis M., Basile V., Meltzer H.Y., Lieberman J.A., Sevy S., Macciardi F.M., Cola P., Howard A., Badri F., Nöthen M.M., Kalow W., Kennedy J.L. Serotonin subtype 2 receptor genes and clinical response to clozapine in schizophrenia patients. Neuropsychopharmacology. 19:1998;123-132.
18. Nimgaonkar V.L., Zhang X.R., Brar J.S., DeLeo M., Ganguli R. 5-HT2 receptor gene locus: association with schizophrenia or treatment response not detected. Psychiatric Genet. 6:1996;23-27.
19. Nöthen M.M., Rietschel M., Erdmann J., Oberländer H., Möller H.-J., Naber D., Propping P. Genetic variation of the serotonin-2A receptor and clinical response to clozapine. Lancet. 346:1995;908-909.
20. Nurnberger J.I., Blehar M.C., Kaufmann C.A., York-Cooler C., Simpson S.G., Harkavy-Friedman J., Severe J.B., Malaspina D., Reich T., Collaborators from the NIMH Genetics Initiative Diagnostic Interview for genetic Studies. Rationale, unique features, and training. Arch. Gen. Psychiatry. 51:1994;849-859.
21. Overall J.E., Gorham D.R. The brief psychiatric rating scale. Psychol. Rep. 10:1962;799-812.
22. Overall, J.E., 1974. A Brief Psychiatric Rating Scale in Psychopharmacology Research. In: Pichot, P., (Ed.), Psychological Measurements Psychopharmacology. Modern Problems in Pharmacopsychiatry, vol. 7. Karger, Basel, pp. 67-78.
23. Rao P.A., Pickar D., Gejman P.V., Ram A., Gershon E.S., Gelernter J. Allelic variation in the D4 dopamine receptor (DRD4) gene does not predict response to clozapine. Arch. Gen. Psychiatry. 51:1994;912-917.
24. 2C receptor. NeuroReport. 8:1997;1999-2003.
25. Rietschel M., Naber D., Oberländer H., Holzbach R., Fimmers R., Möller H.-J., Propping P., Nöthen M.M. Efficacy and side effects of clozapine: testing for association with allelic variation in the dopamine D4 receptor gene. Neuropsychopharmacology. 15:1996;491-496.
26. Shaikh S., Collier D.A., Kerwin R.W., Pilowsky L.S., Gill M., Xu W.M., Thorton A. Dopamine D4 receptor subtypes and response to clozapine. Lancet. 341:1993;116.
27. Shaikh S., Collier D.A., Sham P., Pilowsky L., Sharma T., Lin L.K., Crocq M.A., Gill M., Kerwin R. An analysis of clozapine response and polymorphisms of the dopamine D4 receptor gene (DRD4) in schizophrenic patients. Am. J. Med. Genet. 60:1995;541-545.
28. Sodhi S., Arranz M.J., Curtis D., Ball D.M., Sham P., Roberts G.W., Price J., Collier D.A., Kerwin R. Association between clozapine response and allelic variation in the 5-HT2C receptor gene. NeuroReport. 7:1995;169-172.
29. Spielman R.S., McGinnes R.E., Ewens W.J. Transmission test for linkage disequilibrium: the insulin gene region and insulin-dependent diabetes mellitus (IDDM). Am. J. Hum. Genet. 52:1993;506-516.
30. Spitzer, R.L., Endicott, J., Robins, E., 1978. Research Diagnostic Criteria (RDC). New York Psychiatric Institute, Biometric Research.
31. Spitzer, R.L., Williams, J.B.W., Gibbon, M., First, M.B., 1990. User's Guide for the Structured Clinical Interview for DSM-III-R. American Psychiatric Press, Inc.
32. Wing, J.K., 1970. A standard form of psychiatric present state examination (PSE) and a method for standardising the classification of symptoms. In: Hare, E.H., Wing, J.K. (Eds.), Psychiatric Epidemiology: an International Symposium. Oxford University Press, London.
33. World Health Organization (WHO), 1992. The ICD 10 Classification of Mental and Behavioural Disorders. Clinical Descriptions and Diagnostic Guidelines. WHO, Genf.